Risk Factors of Severe Hypocalcemia after US-guided Percutaneous Microwave Ablation of the Parathyroid Gland in Patients with Secondary Hyperparathyroidism.
Identify potential risk factors associated with severe hypocalcemia (SH) after microwave ablation (MWA) in patients with secondary hyperparathyroidism (SHPT). This retrospective cross-sectional study enrolled 204 consecutive patients (with 387 parathyroid glands) who underwent MWA between July 2015 and May 2018. Clinical parameters, laboratory indices and parathyroid gland characteristics were analyzed to assess risk factors associated with SH after MWA. SH was defined as serum calcium level lower than 1.875 mmol/L (7.5 mg/dL) after MWA. Two models (I and II) for pre-MWA and post-MWA prediction were established respectively. In accordance with the KDIGO guidelines, the target value for iPTH less than 300 pg/ml within 7 days after MWA was considered as a successful procedure. The success rate of MWA was 71.6% (146/204). The incidence of hypocalcemia and SH after MWA was 35.8% and 22.06%, respectively. The pre-MWA prediction Model I and II showed that high pre-MWA intact parathyroid hormone (iPTH)/ a dramatic reduction in iPTH, low pre-MWA serum calcium, multiple ablated gland, and lack of pruritus symptoms were risk factors for developing SH. The accuracy (82.23% vs 83.25% in Models I and II, respectively), sensitivity (34.88% vs 44.19%), specificity (95.45% vs 94.59%), positive predictive value (PPV) (68.18% vs 70.37%) and negative predictive value (NPV) (84.00% vs 85.37%) of both models were promising. The logistic regression fitting of the nomograms showed high prediction efficiency (0.845 and 0.863). High pre-MWA iPTH, dramatic reductions in iPTH, low pre-MWA serum calcium, multiple gland ablation and no pruritus symptoms were predictors of SH. The success rate of the microwave ablation (MWA) procedure was 71.6% (146/204). The incidence of hypocalcemia and severe hypocalcemia (SH) after MWA was 35.8% (37.0% in successful group and 32.8% in unsuccessful group) and 22.06% (24.7% in successful group and 15.5% in unsuccessful group), respectively. The prediction Model I and II showed high pre-MWA iPTH/ a dramatic reduction in iPTH, low pre-MWA serum calcium, multiple ablated glands, and lack of pruritus symptoms were risk factors for developing SH. The accuracy (82.23% vs 83.25% in Models I and II, respectively), sensitivity (34.88% vs 44.19%), specificity (95.45% vs 94.59%), positive predictive value (PPV) (68.18% vs 70.37%) and negative predictive value (NPV) (84.00% vs 85.37%) of both models were promising. To make the prediction model more practical and feasible, two nomograms based on Models I and II were established. The results showed that both nomograms had high prediction efficiency (0.845 and 0.863). Models based on the relevant variables could effectively predict SH, help adjust ablative strategies to avoid SH, or provide timely calcium supplementation to correct SH. Under the guidance of the prediction model, MWA could be performed following planned procedures to control the level of iPTH and avoid SH. The establishment of nomograms according to logistic analyses could simply, directly and effectively show SH prediction.